Login Register Cart 0
Generic placeholder image

Current HIV Research

Editor-in-Chief

ISSN (Print): 1570-162X
ISSN (Online): 1873-4251

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

An Observational Study of Genetic Diversity of HIV-1 vpu in Rapid Progressors in India

Author(s): Poonam Gupta, Arvind Rai, Charoo Hans and Mohammad Husain*

Volume 21, Issue 2, 2023

Published on: 08 March, 2023

Page: [99 - 108] Pages: 10

DOI: 10.2174/1570162X21666230221152633

Price: $65

Abstract

Background: The genetic diversity in HIV-1 genes affects viral pathogenesis in HIV-1 positive patients. Accessory genes of HIV-1, including vpu, are reported to play a critical role in HIV pathogenesis and disease progression. Vpu has a crucial role in CD4 degradation and virus release. The sequence heterogeneity in the vpu gene may affect disease progression in patients, therefore, the current study was undertaken to identify the role of vpu in patients defined as rapid progressors.

Objective: The objective of the study was to identify the viral determinants present on vpu that may be important in disease progression in rapid progressors.

Methods: Blood samples were collected from 13 rapid progressors. DNA was isolated from PBMCs and vpu was amplified using nested PCR. Both strands of the gene were sequenced using an automated DNA Sequencer. The characterization and analysis of vpu was done using various bioinformatics tools.

Results: The analysis revealed that all sequences had intact ORF and sequence heterogeneity was present across all sequences and distributed all over the gene. The synonymous substitutions, however, were higher than nonsynonymous substitutions. The phylogenetic tree analysis showed an evolutionary relationship with previously published Indian subtype C sequences. Comparatively, the cytoplasmic tail(77 – 86) showed the highest degree of variability in these sequences as determined by Entropy- one tool.

Conclusion: The study showed that due to the robust nature of the protein, the biological activity of the protein was intact and sequence heterogeneity may promote disease progression in the study population.

« Previous Next »
Graphical Abstract

[1]
Barré-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220(4599): 868-71.
[http://dx.doi.org/10.1126/science.6189183] [PMID: 6189183]
[2]
Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984; 224(4648): 500-3.
[http://dx.doi.org/10.1126/science.6200936] [PMID: 6200936]
[3]
Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984; 224(4648): 497-500.
[http://dx.doi.org/10.1126/science.6200935] [PMID: 6200935]
[4]
Lifson AR, Buchbinder SR, Sheppard HW, et al. Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: Immunologic and virologic characteristics. J Infect Dis 1991; 163(5): 959-65.
[http://dx.doi.org/10.1093/infdis/163.5.959] [PMID: 1673465]
[5]
Sheppard HW, Lang W, Ascher MS, Vittinghoff E, Winkelstein W. The characterization of non-progressors. AIDS 1993; 7(9): 1159-66.
[http://dx.doi.org/10.1097/00002030-199309000-00002] [PMID: 8105806]
[6]
Phair JP. Keynote address: Variations in the natural history of HIV infection. AIDS Res Hum Retroviruses 1994; 10(8): 883-5.
[http://dx.doi.org/10.1089/aid.1994.10.883] [PMID: 7811537]
[7]
Cao Y, Qin L, Zhang L, Safrit J, Ho DD. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995; 332(4): 201-8.
[http://dx.doi.org/10.1056/NEJM199501263320401] [PMID: 7808485]
[8]
Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995; 332(4): 209-16.
[http://dx.doi.org/10.1056/NEJM199501263320402] [PMID: 7808486]
[9]
Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996; 271(5247): 324-8.
[http://dx.doi.org/10.1126/science.271.5247.324] [PMID: 8553066]
[10]
O’Brien WA, Hartigan PM, Martin D, et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996; 334(7): 426-31.
[http://dx.doi.org/10.1056/NEJM199602153340703] [PMID: 8552144]
[11]
Ho DD. Viral counts count in HIV infection. Science 1996; 272(5265): 1124-5.
[http://dx.doi.org/10.1126/science.272.5265.1124] [PMID: 8638155]
[12]
Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272(5265): 1167-70.
[http://dx.doi.org/10.1126/science.272.5265.1167] [PMID: 8638160]
[13]
Koot M, Keet IPM, Vos AHV, et al. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993; 118(9): 681-8.
[http://dx.doi.org/10.7326/0003-4819-118-9-199305010-00004] [PMID: 8096374]
[14]
Kirchhoff F, Easterbrook PJ, Douglas N, et al. Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease. J Virol 1999; 73(7): 5497-508.
[http://dx.doi.org/10.1128/JVI.73.7.5497-5508.1999] [PMID: 10364298]
[15]
Flores-Villanueva PO, Hendel H, Caillat-Zucman S, et al. Associations of MHC ancestral haplotypes with resistance/susceptibility to AIDS disease development. J Immunol 2003; 170(4): 1925-9.
[http://dx.doi.org/10.4049/jimmunol.170.4.1925] [PMID: 12574360]
[16]
Strebel K. Structure and function of HIV-1 vpu Available at: https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.508.236&rep=rep1&type=pdf
[17]
Uma S, Gupta P, Gupta S, Venkatesh S, Husain M. Comparative genetic variability in HIV-1 subtype C vpu gene in early age group of infants. Curr HIV Res 2018; 18(1): 1-13.
[18]
Strebel K, Klimkait T, Maldarelli F, Martin MA. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J Virol 1989; 63(9): 3784-91.
[http://dx.doi.org/10.1128/jvi.63.9.3784-3791.1989] [PMID: 2788224]
[19]
Cong L, Sugden SM, Leclair P, Lim CJ, Pham TNQ, Cohen ÉA. HIV-1 Vpu promotes phagocytosis of infected CD4+ T cells by macrophages through downregulation of CD47. MBio 2021; 12(4): e01920-1.
[http://dx.doi.org/10.1128/mBio.01920-21] [PMID: 34425695]
[20]
Prévost J, Edgar CR, Richard J, et al. HIV-1 Vpu downregulates tim-3 from the surface of infected CD4+ T cells. J Virol 2020; 94(7): e01999-19.
[http://dx.doi.org/10.1128/JVI.01999-19] [PMID: 31941771]
[21]
Gupta P, Husain M, Hans C, et al. Sequence heterogeneity in human immunodeficiency virus type 1 NEF in patients presenting with rapid progression and delayed progression to AIDS. Arch Virol 2014; 159(9): 2303-20.
[http://dx.doi.org/10.1007/s00705-014-2026-2] [PMID: 24748005]
[22]
Lee CN, Wang WK, Fan WS, et al. Determination of human immunodeficiency virus type 1 subtypes in Taiwan by VPU gene analysis. J Clin Microbiol 2000; 38(7): 2468-74.
[http://dx.doi.org/10.1128/JCM.38.7.2468-2474.2000] [PMID: 10878027]
[23]
Choi Y, Chan AP. PROVEAN web server: A tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 2015; 31(16): 2745-7.
[http://dx.doi.org/10.1093/bioinformatics/btv195] [PMID: 25851949]
[24]
Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS One 2012; 7(10): e46688.
[http://dx.doi.org/10.1371/journal.pone.0046688] [PMID: 23056405]
[25]
Choi Y. In: A fast computation of pairwise sequence alignment score between a protein and a set of singl-locus variants of another protein, Proceedings of the ACM Conference on Bioinformatics, Computational Biology and Biomedicine (BCB' 12) Orlando, Florida, 2012, New York, USA: ACM 2012; pp. 414-7.
[http://dx.doi.org/10.1145/2382936.2382989]] [PMID: 15718475]
[26]
Kumar M, Jain SK, Pasha ST, Chattopadhaya D, Lal S, Rai A. Genomic diversity in the regulatory nef gene sequences in Indian isolates of HIV type 1: Emergence of a distinct subclade and predicted implications. AIDS Res Hum Retroviruses 2006; 22(12): 1206-19.
[http://dx.doi.org/10.1089/aid.2006.22.1206] [PMID: 17209762]
[27]
Tamura K, Nei M. Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 1993; 10(3): 512-26.
[PMID: 8336541]
[28]
Kumar S, Stecher G, Tamura K. MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 2016; 33(7): 1870-4.
[http://dx.doi.org/10.1093/molbev/msw054] [PMID: 27004904]
[29]
McCormick-Davis C, Dalton SB, Singh DK, Stephens EB. Comparison of Vpu sequences from diverse geographical isolates of HIV type 1 identifies the presence of highly variable domains, additional invariant amino acids, and a signature sequence motif common to subtype C isolates. AIDS Res Hum Retroviruses 2000; 16(11): 1089-95.
[http://dx.doi.org/10.1089/08892220050075363] [PMID: 10933625]
[30]
Willey RL, Maldarelli F, Martin MA, Strebel K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol 1992; 66(12): 7193-200.
[http://dx.doi.org/10.1128/jvi.66.12.7193-7200.1992] [PMID: 1433512]
[31]
Schubert U, Strebel K. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J Virol 1994; 68(4): 2260-71.
[http://dx.doi.org/10.1128/jvi.68.4.2260-2271.1994] [PMID: 8139011]
[32]
Terwilliger EF, Cohen EA, Lu YC, Sodroski JG, Haseltine WA. Functional role of human immunodeficiency virus type 1 vpu. Proc Natl Acad Sci USA 1989; 86(13): 5163-7.
[http://dx.doi.org/10.1073/pnas.86.13.5163] [PMID: 2472639]
[33]
Klimkait T, Strebel K, Hoggan MD, Martin MA, Orenstein JM. The human immunodeficiency virus type 1-specific protein Vpu is required for efficient virus maturation and release. J Virol 1990; 64(2): 621-9.
[http://dx.doi.org/10.1128/jvi.64.2.621-629.1990] [PMID: 2404139]
[34]
Verma S, Ali A, Arora S, Banerjea AC. Inhibition of β-TrcP–dependent ubiquitination of p53 by HIV-1 Vpu promotes p53–mediated apoptosis in human T cells. Blood 2011; 117(24): 6600-7.
[http://dx.doi.org/10.1182/blood-2011-01-333427] [PMID: 21521785]
[35]
Sandberg JK, Andersson SK, Bächle SM, Nixon DF, Moll M. HIV-1 Vpu interference with innate cell-mediated immune mechanisms. Curr HIV Res 2012; 10(4): 327-33.
[http://dx.doi.org/10.2174/157016212800792513] [PMID: 22524181]
[36]
Moll M, Andersson SK, Smed-Sörensen A, Sandberg JK. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Blood 2010; 116(11): 1876-84.
[http://dx.doi.org/10.1182/blood-2009-09-243667] [PMID: 20530791]
[37]
Ramirez PW, Famiglietti M, Sowrirajan B, et al. Downmodulation of CCR7 by HIV-1 Vpu results in impaired migration and chemotactic signaling within CD4⁺ T cells. Cell Rep 2014; 7(6): 2019-30.
[http://dx.doi.org/10.1016/j.celrep.2014.05.015] [PMID: 24910430]
[38]
Gray CM, Mlotshwa M, Riou C, et al. Human immunodeficiency virus-specific gamma interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set point. J Virol 2009; 83(1): 470-8.
[http://dx.doi.org/10.1128/JVI.01678-08] [PMID: 18945774]
[39]
Nomaguchi M, Fujita M, Adachi A. Role of HIV-1 Vpu protein for virus spread and pathogenesis. Microbes Infect 2008; 10(9): 960-7.
[http://dx.doi.org/10.1016/j.micinf.2008.07.006] [PMID: 18672082]
[40]
Tiganos E, Yao XJ, Friborg J, Daniel N, Cohen EA. Putative α-helical structures in the human immunodeficiency virus type 1 Vpu protein and CD4 are involved in binding and degradation of the CD4 molecule. J Virol 1997; 71(6): 4452-60.
[http://dx.doi.org/10.1128/jvi.71.6.4452-4460.1997] [PMID: 9151836]
[41]
Cordes FS, Kukol A, Forrest LR, Arkin IT, Sansom MSP, Fischer WB. The structure of the HIV-1 Vpu ion channel: Modelling and simulation studies. Biochim Biophys Acta Biomembr 2001; 1512(2): 291-8.
[http://dx.doi.org/10.1016/S0005-2736(01)00332-7] [PMID: 11406106]
[42]
Fischer WB. Vpu from HIV-1 on an atomic scale: Experiments and computer simulations. FEBS Lett 2003; 552(1): 39-46.
[http://dx.doi.org/10.1016/S0014-5793(03)00782-8] [PMID: 12972150]
[43]
Mehnert T, Routh A, Judge PJ, et al. Biophysical characterization of Vpu from HIV-1 suggests a channel-pore dualism. Proteins 2008; 70(4): 1488-97.
[http://dx.doi.org/10.1002/prot.21642] [PMID: 17910056]
[44]
Padhi S, Burri RR, Jameel S, Priyakumar UD. Atomistic detailed mechanism and weak cation-conducting activity of HIV-1 Vpu revealed by free energy calculations. PLoS One 2014; 9(11): e112983.
[http://dx.doi.org/10.1371/journal.pone.0112983] [PMID: 25392993]
[45]
Bonifacino JS, Traub LM. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem 2003; 72(1): 395-447.
[http://dx.doi.org/10.1146/annurev.biochem.72.121801.161800] [PMID: 12651740]
[46]
Ruiz A, Hill MS, Schmitt K, Guatelli J, Stephens EB. Requirements of the membrane proximal tyrosine and dileucine-based sorting signals for efficient transport of the subtype C Vpu protein to the plasma membrane and in virus release. Virology 2008; 378(1): 58-68.
[http://dx.doi.org/10.1016/j.virol.2008.05.022] [PMID: 18579178]
[47]
Estrabaud E. Le, Rouzic E, Lopez-Verges S, et al. Regulated degradation of the HIV-1 Vpu protein through a bTrCP-independent pathway limits the release of viral particles. PLoS Pathog 2007; 3(7): e104.
[http://dx.doi.org/10.1371/journal.ppat.0030104] [PMID: 17676996]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy